CRIS Current Research Information System

GIOVANNINI, CATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.160
NA - Nord America 4.068
EU - Europa 3.206
AF - Africa 259
SA - Sud America 240
Continente sconosciuto - Info sul continente non disponibili 228
OC - Oceania 5
Totale 12.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.955
IT - Italia 1.182
CN - Cina 1.140
SG - Singapore 1.049
VN - Vietnam 910
GB - Regno Unito 453
HK - Hong Kong 279
DE - Germania 255
SE - Svezia 246
FR - Francia 186
NL - Olanda 183
IN - India 178
BR - Brasile 173
KR - Corea 157
CH - Svizzera 130
BD - Bangladesh 104
RU - Federazione Russa 98
FI - Finlandia 91
UA - Ucraina 88
IE - Irlanda 86
JP - Giappone 85
CA - Canada 69
ZA - Sudafrica 65
CI - Costa d'Avorio 59
TG - Togo 49
BG - Bulgaria 39
ID - Indonesia 34
SC - Seychelles 34
PH - Filippine 32
JO - Giordania 31
EE - Estonia 30
TH - Thailandia 29
EC - Ecuador 25
PL - Polonia 23
BE - Belgio 21
PK - Pakistan 21
ES - Italia 18
MX - Messico 18
TR - Turchia 18
AR - Argentina 17
AT - Austria 15
NG - Nigeria 14
TW - Taiwan 13
DZ - Algeria 12
SA - Arabia Saudita 11
CZ - Repubblica Ceca 9
IL - Israele 9
IQ - Iraq 9
MK - Macedonia 9
UZ - Uzbekistan 9
HR - Croazia 8
GR - Grecia 7
JM - Giamaica 7
MY - Malesia 7
RO - Romania 7
TN - Tunisia 7
CO - Colombia 6
LT - Lituania 6
NP - Nepal 6
AU - Australia 5
LB - Libano 5
AM - Armenia 4
ET - Etiopia 4
PE - Perù 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
BZ - Belize 2
GH - Ghana 2
HN - Honduras 2
KZ - Kazakistan 2
MD - Moldavia 2
PR - Porto Rico 2
SI - Slovenia 2
SN - Senegal 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
Totale 11.928
Salva come PNG Salva come JPEG
Città #
Singapore 728
Ashburn 492
Southend 355
Bologna 338
Hefei 321
San Jose 281
Hong Kong 253
Fairfield 247
Chandler 225
Ho Chi Minh City 218
Hanoi 191
Council Bluffs 166
Santa Clara 153
Seoul 142
Boardman 136
Houston 120
Bern 119
Wilmington 119
Woodbridge 118
Milan 114
Beijing 110
Seattle 89
Dublin 86
Los Angeles 82
Dallas 81
Princeton 81
Ann Arbor 77
New York 75
Helsinki 73
Cambridge 72
Lauterbourg 70
Tokyo 64
Abidjan 59
Jacksonville 53
Lomé 49
Florence 41
Da Nang 40
Sofia 38
Dong Ket 37
São Paulo 36
Turin 36
Nanjing 35
Chicago 34
Padova 34
Buffalo 33
Westminster 33
Haiphong 32
Amman 31
Bengaluru 30
Johannesburg 30
Amsterdam 29
Rome 29
Redondo Beach 26
Berlin 25
Munich 25
Rimini 25
Jinan 24
Jakarta 22
San Diego 22
Montreal 21
Frankfurt am Main 20
London 20
Shanghai 18
Brooklyn 17
Changsha 17
Phoenix 17
Saint Petersburg 17
Guangzhou 16
Hebei 16
Orem 16
Verona 16
Warsaw 15
Brussels 14
Düsseldorf 14
Pune 14
Genoa 13
Imola 13
Jiaxing 13
Modena 13
Philadelphia 13
Shenyang 13
The Dalles 13
Zhengzhou 13
Can Tho 12
Curitiba 12
Lahore 12
Abeokuta 11
Atlanta 11
Bangkok 11
Chennai 11
Medford 11
Mülheim 11
Nuremberg 11
Tongling 11
Edmonton 10
Guayaquil 10
Haikou 10
Hangzhou 10
Hải Dương 10
Norwalk 10
Totale 7.260
Salva come PNG Salva come JPEG
Nome #
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 334
Organic Electrochemical Transistor (OECT) for Real Time, Electrical quantification of SARS CoV 2 neutralizing antibodies 275
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 273
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 271
Metodo per valutare la capacità di un siero di neutralizzare un virus 265
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 245
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 239
Fast and real-time electrical transistor assay for quantifying SARS-CoV-2 neutralizing antibodies 235
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 233
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 232
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma 228
LncRNAs as novel players in hepatocellular carcinoma recurrence 228
Synthetic torpor triggers a regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation 222
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland 220
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 218
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 206
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 202
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 192
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 190
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 189
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 189
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 188
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) 188
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 185
Determinazione della telomerasi nei tumori mammari della cagna: due metodi a confronto 183
Fibrous hamartoma of corpus cavernosum: a rare cause of congenital penile curvature associated with erectile dysfunction. 183
Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. 183
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 182
CARCINOMA COMPLETAMENTE NEUROENDOCRINO DELLA VESCICA IN GIOVANE PAZIENTE DI 37 ANNI: CASO CLINICO 179
PEDOT:PSS OECTs as versatile devices for real-time monitoring of cytotoxicity and viral infection 177
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 176
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 170
Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease 169
Pharmaceutical composition and pharmaceutical kit for the treatment oh hepatocellular carcinoma 167
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 165
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research 163
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 161
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 161
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies 160
OECTs for in-vitro, real-time impedance monitoring: from single cell sensing to tissue integrity 160
Organic Electrochemical Transistors as Versatile Tool for Real-Time and Automatized Viral Cytopathic Effect Evaluation 159
Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation. 158
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions 155
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC 154
MicroRNAs in Animal Models of HCC 150
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. 144
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 143
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells 142
Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. 142
Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Anticancer Res. 2006 May-Jun;26(3A):1849-54. 141
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. 140
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 138
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA 131
p66Shc/Notch-3 interplay controls self renewal and hypoxia survival inhuman stem/progenitor cells of the mammary gland expanded in vitro as mammo-spheres. 127
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma 117
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas 115
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma 115
Notch3 intracellular domain accumulates in HepG2 cell line. 112
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 110
Expression of Fli-1 leads to increased notch activity through overexpression of fringe in colorectal cancer (CRC). 108
Checkpoint effectors CDKN1A and Gadd45 correlate with oxidative DNA damage in human prostate carcinoma. 105
Corrigendum: Synthetic torpor triggers a regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation (Frontiers in Physiology, (2023), 14, (1129278), 10.3389/fphys.2023.1129278) 96
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 94
PEDOT:PSS OECTs as versatile devices for real-time monitoring cytotoxicity and viral infection 91
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 80
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 80
PEDOT:PSS OECTs as versatile devices for monitoring cytotoxicity and viral infection in real-time 79
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 78
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 77
Scaling up in-vitro, real-time cell monitoring through large area printing of PEDOT:PSS OECTs 76
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 74
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 72
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 64
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 62
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 56
Organic Electrochemical Transistors for Real-Time Detection of Immune System Early Activation during Atezolizumab-Bevacizumab Treatment in Hepatocellular Carcinoma 48
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma 47
Totale 12.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022837 0 35 63 84 69 44 16 79 37 81 211 118
2022/20231.201 111 135 83 132 68 100 22 65 185 29 94 177
2023/2024508 38 61 22 48 31 96 31 46 30 44 26 35
2024/20251.832 86 220 168 105 191 72 140 69 71 181 150 379
2025/20265.305 447 500 425 380 425 274 556 223 1.044 357 295 379
2026/2027553 372 181 0 0 0 0 0 0 0 0 0 0
Totale 12.166